These sections summarize data on the use of antiviral agents for the treatment of COVID-19.
These sections summarize data on corticosteroids, IL-6 inhibitors, JAK inhibitors, and other immunomodulators.
This section discusses thromboembolism screening, prevention, and treatment in people with COVID-19.
These sections summarize data on metformin, fluvoxamine, and other miscellaneous drugs.
These sections provide information on the evaluation of supplements in COVID-19 care.
This section offers guidance on the use of concomitant medications in people with COVID-19.